REQUEST A DEMO
Total
USD $0.00
Search more companies

Cymbio Pharma Private Limited (India)

Main Activities: Health Care and Social Assistance
Full name: Cymbio Pharma Private Limited Profile Updated: December 15, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Cymbio Pharma Private Limited is an unlisted company, incorporated on 14/09/1998. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U85110KA1998PTC024210 and registration number is 024210. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Headquarters
No.23/4Venkatala Yelahanka Hobli Yelahanka Bangalore In-Ka In 560064
Bangalore; Karnataka; Postal Code: 560064

Contact Details: Purchase the Cymbio Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Cymbio Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Cymbio Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Cymbio Pharma Private Limited report to view the information.
Incorporation Date:
September 14, 1998
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Cymbio Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
29.63%
Total operating revenue
30.58%
Operating profit (EBIT)
N/A
EBITDA
1911.13%
Net Profit (Loss) for the Period
N/A
Total assets
13.02%
Total equity
25.76%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
30.28%
Quick Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?